The Technology Tree of Xueba

After the sudden construction of Xinghuo Biological Company, the factory was finally built.

On December 2, Zhou Yu visited the factory not far from the company's headquarters.

Wang Jian led Zhou Yu to visit the factory and also introduced the latest situation of the products.

"Director Wang Xiaoxiao leads scientific researchers at the Life Science Research Institute and cooperates with major medical institutions in Yanjing to conduct clinical trials of three products.

After the documentary advertisement aired, many critically ill patients applied for clinical trials.

Their joining has improved the data of many diseases, making the clinical trial progress very fast, and the competent department also sent experts to stare at the clinical trial data.

Because of the pressure in the society, many celebrities and veteran cadres wrote letters to competent authorities to let them quickly review cell missiles and other products.

After the competent authority has determined the safety and real effects of our products, we have reviewed and approved the drugs we have declared, and the drug registration number has been issued and can be officially marketed. "

"Things are going very well. Let's first look at the condition of the factory. Normal production of medicines is sufficient and we will start to market.

I have instructed Spark Intelligent Company that they have trained the AI ​​sages, and there will be AI sages to guide doctors to take medicine. Zhou Yu said happily.

He knows that after the three drugs are on the market, they will definitely be targeted by domestic and foreign pharmaceutical groups, but these three drugs are all drugs that benefit the country and the people.

According to expert estimates, they can at least increase Huaxia's average life expectancy by 5 years, and can reduce the death rate of children under the age of 95%.

At the same time, it also surpassed artificial intelligence and software games, becoming the most profitable project of Spark Technology.

For the benefit and reputation of Spark Technology, they are now not afraid of any challenges.

As long as you are not capable of erasing Spark Technology from the earth, fighting commercial wars, and other battles, now Spark Technology has no fear at all.

Wang Jian took Zhou Yu into the factory. Inside were huge glass jars.

The glass jar is strictly sealed, the product is completely kept in a sterile state, the glass jar shows a holographic image, and there are numerous sensors to monitor every data of the product.

Zhou Yu already knew about the production process of pharmaceuticals with Director Wang Xiaoxiao.

In addition to disease screening agents, the other two are inspiration for studying hematopoietic stem cells.

The production of these three agents is also inseparable from cell culture technology, which is actually a veritable cell factory.

Zhou Yu and Wang Jian walked to the production workshop, which is in front of equipment consisting of thousands of small cans, which are the production equipment for disease screening drugs.

Zhou Yu immediately remembered the process of disease screening drug production.

Disease screening agents are a complex set of peptide solutions. More than 1,000 peptides are mixed together to form disease screening agents.

Each peptide can and can only react with a type of pheromone in human plasma. The result of the reaction is the folding of the polypeptide chain to form a fluorescent protein.

Just test the type of fluorescent protein in the reagent. It is possible to read out the diseases suffered by the sample provider.

Each peptide is expressed by a small piece of gene constructed by modern gene technology, and the gene fragment is transplanted into a yeast cell selected in the laboratory.

During the proliferation of yeast cells, a large amount of peptide material is produced.

When all peptides are mixed together, they become disease screening agents.

Wang Jian introduced to Zhou Yu: "The disease screening agent is a peptide solvent. The optimal storage temperature is about zero. Once the temperature exceeds 40 degrees, the polypeptide chain will automatically dehydrate and condense, losing the effect of detecting diseases.

Each disease screening medicament is made into a small finger-sized reagent bottle and transported to a medical institution by a special vehicle.

The equipment for disease screening drugs has been handed over to Xinghuo Precision Manufacturing Co., and they have many orders. "

Zhou Yu and Wang Jian walked to the production workshop on the left. There are many glass jars filled with red liquid and light yellow liquid. At first glance, it is the production equipment of blood cells and plasma.

The technology of plasma production is very simple, water accounts for about 92%, most of which are plasma proteins, containing a small amount of nutrients, electrolytes, enzymes, hormones and so on.

As long as the optimal ratio is mastered, it is easy to synthesize plasma.

The real difficulty is the production of blood cells, especially platelets and red blood cells, which are functional cells that play a decisive role in the blood. The cells produced by the industry must have cellular activity.

Director Wang Xiaoxiao cultivated hematopoietic stem cells similar to cancer cells through genetic modification technology.

This genetically modified hematopoietic stem cell is completely different from cancer cells.

Cancer cells have infinite proliferation capacity, but they have lost their ability to differentiate.

Genetically modified hematopoietic stem cells have the unlimited proliferation capacity of cancer cells, but they still retain the ability to differentiate into functional cells.

When hematopoietic stem cells are cultured in nutrients, they have infinite proliferation capacity and can rapidly self-proliferate.

Once induced by chemical reagents, such hematopoietic stem cells will differentiate into corresponding blood cells, mainly red blood cells, white blood cells and platelets.

Wang Jian pointed at these tanks and introduced: "This is the artificial blood produced by our company. Now it can produce 10 tons of artificial blood every day.

We package various types of blood, and our company has its own transportation fleet to transport the finished blood through professional vehicles.

We also cooperate with the Railway Corporation to transport blood through the high-speed rail network by mounting special high-speed rail cars. "

Zhou Yu heard Wang Jian's introduction. He was a bit surprised. The method of cooperating with the Railway Corporation was entirely Wang Jian's own talk.

This method is really good. The fastest is air transportation, but the transportation of artificial blood is high, and the aircraft needs to be modified, so the transportation cost is too high.

The rest is the cost of transforming a carriage by high-speed rail, which Xinghuo Biological Company can bear, but the most important issue is to open the channel of the railway company.

"You have done a great job with this matter. If it is really emergency blood, you can send people on a small scale to carry it by air. The way of factory transportation is really a good choice." Zhou Yu praised. UU reading books www.uukanshu.com

They finally came to the cell missile production workshop, which is also a huge giant jar.

Cell missile production technology is similar to hematopoietic stem cells. It first stimulates lymphatic B cells with antigens and allows them to produce plasma cells that can produce specific antibodies.

Later, through genetic modification technology, plasma cells have infinite proliferation ability, and at the same time, the ability to generate antibodies is changed by modifying the gene.

In this way, the genetically modified plasma cells are placed in the culture medium, and it can continuously produce the same antibodies.

Wang Jian introduced: "The cell missile is a mature protein antibody. It adapts very well to ultra-low temperatures and can withstand high temperatures of about 50 degrees.

It only needs to change the packaging material, and it can be transported at normal temperature. "

Zhou Yu looked at a huge cell factory that operated autonomously without anyone.

He said with emotion: "This is not a very large cell factory that will rewrite the trajectory of human medical development."